Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features

Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer’s disease (AD). Early identification of underlying neurodegenerative processes is essential to provide treatment before the disease is well established in the brain. Here we used longitudinal data from the ADN...

Full description

Bibliographic Details
Main Authors: Ingrid Rye, Alexandra Vik, Marek Kocinski, Alexander S. Lundervold, Astri J. Lundervold
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-18805-5